Specific Association of the β Isoform of the p85 Subunit of Phosphatidylinositol-3 Kinase with the Proto-oncogene c-cbl
Open accessThe DOI matches its Crossref record.
Abstract
Phosphatidylinositol-3 kinase (PI-3 kinase) has been implicated in cellular events such as mitogenic signaling, actin organization, and receptor sorting. The p85 subunit of PI-3 kinase contains multiple domains capable of protein-protein interactions that may contribute to mediate the multiple physiological functions of this enzyme. Here, we demonstrate that antibodies raised against the p85 subunit of PI-3 kinase immunoprecipitate a single tyrosine-phosphorylated protein of 120 kDa (pp120) from lysates of activated Jurkat T cells and A20 B cells. This protein is the only significant phosphotyrosine-containing protein in p85 immunoprecipitates from these cells, and it cannot be detected in immunoprecipitates of other signaling proteins such as PLC gamma. Furthermore, antibodies specific for the beta isoform of p85 but not antibodies specific for the alpha isoform immunoprecipitate this tyrosine-phosphorylated protein. pp120 completely comigrates with the proto-oncogene c-cbl, which is a 120 kDa protein product abundant in lymphoid cells. Furthermore, immunoblots of p85 immunoprecipitates using antibodies raised against c-cbl detect a band at exactly the position of pp120. In addition, p85 can be detected in immunoblots of c-cbl immunoprecipitates. Thus, pp120 appears to correspond to c-cbl. A direct association between c-cbl and p85 can be observed in vitro using a fusion protein comprising the Src homology 2 (SH2) domains of p85, and this binding is abolished by phenyl phosphate, suggesting that the interaction is mediated through phosphotyrosine-SH2 domain interactions. Thus, these results show important functional differences between the alpha and beta isoforms of p85 in vivo and point to c-cbl as a potentially important mediator of some of the functions of PI-3 kinase in intact cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Signaling by Distinct Classes of Phosphoinositide 3-Kinases
Vanhaesebroeck, B., & Waterfield, M. D. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4701 · Cited by 853
Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
Lennartsson, J., & Rönnstrand, L. (2012) · Physiological Reviews · doi:10.1152/physrev.00046.2011 · Cited by 825
Signal transduction via the stem cell factor receptor/c-Kit
R�nnstrand, L. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4189-6 · Cited by 450
A requirement for phosphatidylinositol 3-kinase in pseudopod extension
Cox, D., Tseng, C.-C., Bjekic, G., & Greenberg, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1240 · Cited by 410
p110δ, a novel phosphoinositide 3-kinase in leukocytes
Vanhaesebroeck, B., Welham, M. J., Kotani, K., Stein, R., Warne, P. H., Zvelebil, M. J., Higashi, K., Volinia, S., Downward, J., & Waterfield, M. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4330 · Cited by 376
Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases
Waterman, H., & Yarden, Y. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02117-2 · Cited by 314
The Cbl family proteins: Ring leaders in regulation of cell signaling
Swaminathan, G., & Tsygankov, A. Y. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20694 · Cited by 291
Influenza A virus NS1 protein binds p85β and activates phosphatidylinositol-3-kinase signaling
Hale, B. G., Jackson, D., Chen, Y.-H., Lamb, R. A., & Randall, R. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606109103 · Cited by 286
The complexity of signaling pathways activated by the BCR
DeFranco, A. L. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80074-x · Cited by 251
Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase
Ueki, K., Yballe, C. M., Brachmann, S. M., Vicent, D., Watt, J. M., Kahn, C. R., & Cantley, L. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012581799 · Cited by 234
Yu, Y., & Sato, J. D. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199902)178:2<235::aid-jcp13>3.0.co;2-s · Cited by 212
The SH2 domain: versatile signaling module and pharmaceutical target
Machida, K., & Mayer, B. J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.005 · Cited by 206
Fine tuning the immune response with PI3K
Fruman, D. A., & Bismuth, G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00750.x · Cited by 199
Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus
Saeed, M. F., Kolokoltsov, A. A., Freiberg, A. N., Holbrook, M. R., & Davey, R. A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000141 · Cited by 198
“, indicating that each subtype may have specialized roles in specific cells and tissues. Indeed, each binds different sets of proteins”
BackgroundFeshchenko, E. A., Langdon, W. Y., & Tsygankov, A. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8323 · Cited by 159
Metadata
- Authors
- Hartley, D., Meisner, H., & Corvera, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-08
- Volume
- 270
- Issue
- 31
- Pages
- 18260-18263
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2094228209
- Cited by
- 95
- References
- 0
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.